American Association for the Study of Liver Diseases (AASLD)

Representing more than 3,700 practitioners, researchers, and allied health professionals, the American Association for the Study of Liver Diseases (AASLD) is focused solely on advancing the science and practice of hepatology. For generations, AASLD has been a catalyst for the investigation and treatment of liver diseases. AASLD upholds the standards of the profession and fosters research that generates treatment options for the millions of patients with liver diseases. Mentoring, sharing knowledge and dedication to professional growth and development are among the core values of AASLD and its members. To learn more about AASLD’s activities – including The Liver Meeting® – visit us at http://www.aasld.org.

AIO

Arbeitsgemeinschaft Internistische Onkologie in der Deutschen Krebsgesellschaft e.V. (AIO)

The main task of the “Working Group Medical Oncology within German Cancer Society” (AIO) is located in the realization of clinical trials and the quality assurance of medicinal cancer treatment.
The purpose of the AIO is the close collaboration of professionals, concerned with treatment of oncologic diseases as well as collaboration with adjoining clinical disciplines and basic research to achieve a state-of-the-art medical care of oncologic diseases.
The exploratory focus of the AIO related to clinical studies is on optimization of already approved therapies including the application of new substances (targeted therapies) and translational analysis of predictive markers.

apasl

The Asian Pacific Association for the Study of the Liver (APASL)

The Asian Pacific Association for the Study of the Liver (APASL) was formed in August 1978 in Singapore. APASL covers the region from China, Mongolia and Kazakhstan in the North, to New Zealand in the South, to the Pacific Islands in the East and Turkey and Egypt in the West. Our main objective of the association is to promote the scientific advancement and education of hepatology in the Asia Pacific region, including the exchange of information and the development of consensus in the field of hepatology. It coordinates scientific studies between scientists and clinicians living in this region and encourages the practice of medicine in liver diseases.

m_logo

The Asia-Pacific Primary Liver Cancer Expert Association

The Asia-Pacific Primary Liver Cancer Expert (APPLE) Association was established in 2010. APPLE Meeting covers all over the Asian countries. Our main objective of the association is to promote the scientific advancement and education of liver cancer management in the Asia-Pacific region, where 80% of global liver cancer deaths arise including the exchange of information and the development of consensus in the field of liver cancer.

Our activities include;
1. Holds scientific conference once a year.
2. Mutual relationship with ILCA by inviting the many leadership to the annual conference.
3. Consensus development in liver cancer management in the Asia-Pacific region.
4. Publish official journal “LIVER CANCER”
(http://www.karger.com/Journal/Home/255487)

ASCO

American Society of Clinical Oncology (ASCO)

The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer. With more than 30,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation, which funds ground-breaking research and programs that make a tangible difference in the lives of people with cancer. For ASCO information and resources, visit www.asco.org. Patient-oriented cancer information is available at www.cancer.net.

bf-round-logo

Blue Faery: The Adrienne Wilson Liver Cancer Association

Blue Faery: The Adrienne Wilson Liver Cancer Association is devoted to fighting primary liver cancer. Founded in Burbank, California, with a satellite location in Birmingham, Alabama, Blue Faery’s mission is to prevent, treat and cure primary liver cancer, specifically Hepatocellular Carcinoma (HCC), through research, education and advocacy. Visit www.bluefaery.org.

CanLiv-bearbeitet

CanLiv – The Hepatobiliary Cancers Foundation

CanLiv – The Hepatobiliary Cancers Foundation is a 501c(3) non-profit medical education and research foundation. CanLiv’s mission is to improve the treatment options and survival for patients with cancers of the bile ducts, gallbladder and liver. CanLiv provides patient education materials, fosters a sense of community among all stakeholders, drives advances in science by sponsoring an annual CanLiv Research Symposium.

cirse

Cardiovascular and Interventional Radiology Society of Europe (CIRSE)

CIRSE is the most comprehensive European platform for Cardiovascular and Interventional Radiology; it aims to provide continuing education and training to physicians and scientists with an active interest in interventional radiology or cardiovascular imaging techniques and stands to promote the exchange of ideas and information to further define the role, direction and goals of cardiovascular and interventional radiology as a subspecialty of radiology.

easl

European Association for the Study of the Liver (EASL)

The European Association for the Study of the Liver (EASL) is the leading European association in the field of liver research. EASL brings together clinicians and scientists interested in the liver, providing an outlet for networking and learning.

JSH

The Japan Society of Hepatology (JSH)

The Japan Society of Hepatology encourages research on hepatology and contributes to the development of this medical discipline by publishing research reports on hepatology and exchanging knowledge. In order to achieve its objectives, The Japanese Society of Hepatology:

  1. Holds academic conferences and lectures on hepatology
  2. Publishes the journals “Kanzo” in Japanese and “Hepatology Research” in English.
  3. Collaborates with research organizations in and abroad.
  4. Conducts other activities that help the Society to achieve its objectives.